Drug Profile
Estradiol/trimegestone
Alternative Names: Estradiol/trimegestone oral; Totelle; Totelle Ciclico; Totelle Continuo; Totelle Cycle; Totelle Sekvens; Trimegestone/estradiol oralLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator sanofi-aventis; Wyeth
- Developer Pfizer; Wyeth
- Class Estradiol congeners; Estrenes; Hormonal replacements; Norpregnadienes
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Menopausal syndrome; Postmenopausal osteoporosis
Most Recent Events
- 16 Aug 2010 Launched for Postmenopausal osteoporosis in European Union (PO)
- 16 Oct 2009 Wyeth has been acquired by Pfizer
- 17 Mar 2009 Launched for Menopausal syndrome in Europe (PO)